Idexx Laboratories
IDXX
582 hedge funds and large institutions have $12.5B invested in Idexx Laboratories in 2017 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 198 increasing their positions, 219 reducing their positions, and 33 closing their positions.
145% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 33
8% more funds holding
Funds holding: 541 → 582 (+41)
2% more capital invested
Capital invested by funds: $12.2B → $12.5B (+$255M)
10% less repeat investments, than reductions
Existing positions increased: 198 | Existing positions reduced: 219
2.33% less ownership
Funds ownership: 90.01% → 87.67% (-2.3%)
22% less funds holding in top 10
Funds holding in top 10: 23 → 18 (-5)
26% less call options, than puts
Call options by funds: $19.9M | Put options by funds: $26.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$152M |
| 2 |
BlackRock
New York
|
+$109M |
| 3 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$84.2M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$63.8M |
| 5 |
Renaissance Technologies
New York
|
+$61.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$265M |
| 2 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$240M |
| 3 |
Select Equity Group
New York
|
-$103M |
| 4 |
JP Morgan Chase
New York
|
-$58.4M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$56M |
IDXX Hedge Fund Activity: Q2 2017 in Review
582 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q2 2017, worth a combined $12.5B — up 2.1% from $12.2B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new IDXX positions and 33 closed out — a net gain of 48 holders — while 198 added to existing stakes and 219 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $152M. The largest seller was T. Rowe Price Associates, cutting an estimated $265M.
- 582 institutional investors held Idexx Laboratories (IDXX) as of Q2 2017, up from 541 in Q1 2017.
- Funds reported $12.5B of Idexx Laboratories stock for Q2 2017, up 2.1% quarter-over-quarter.
- 81 funds opened new Idexx Laboratories positions in Q2 2017 and 33 closed out, a net change of +48 holders.
- The largest Idexx Laboratories buyer in Q2 2017 was Janus Henderson Group, an estimated $152M added.
- The largest Idexx Laboratories seller in Q2 2017 was T. Rowe Price Associates, an estimated $265M sold.
Based on aggregated 13F filings for Q2 2017.